Patients will receive standard dose CLAG-M (cladribine, cytarabine, mitoxantrone, filgrastim). Standard support care will be given. Efficacy will be assessed through bone marrow examinations and blood tests.
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Relapsed or refractory acute lymphoblastic leukemia,
Burkitts leukemia/lymphoma,
Lymphoid blastic CML,
Lymphoblastic lymphoma.
Clareo Health | Trial of Cladribine, Cytarabine, Mitoxantrone, Filgrastim (CLAG-M) in Relapsed Acute Lymphoblastic Leukemia
